Skip to main content
PMC home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1989 Apr;150(4):431–435.

Diagnosing and treating active myocarditis.

J B O'Connell, J W Mason
PMCID: PMC1026578  PMID: 2660415

Abstract

The treatment of dilated cardiomyopathy is palliative and, hence, has little effect on the natural history. Therapy directed toward the cause rather than the effect will be necessary before mortality can be affected. Active myocarditis is postulated to be the cause of dilated cardiomyopathy in a subset of patients. A model of murine coxsackievirus B3 myocarditis has immunopathogenic parallels to the disease in humans and suggests that persistent autoimmune reactivity following viral clearance leads to progressive myocyte damage and dilated cardiomyopathy. In preliminary uncontrolled studies, patients with myocarditis have shown clinical and histologic improvement with the addition of immunosuppressive therapy, but there may also be a significant rate of spontaneous improvement. A multicenter study currently acquiring patients is designed to determine the efficacy of immunosuppression and the natural history of active myocarditis.

Full text

PDF
431

Images in this article

433Image
on p.433

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aretz H. T., Billingham M. E., Edwards W. D., Factor S. M., Fallon J. T., Fenoglio J. J., Jr, Olsen E. G., Schoen F. J. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol. 1987 Jan;1(1):3–14. [PubMed] [Google Scholar]
  2. Bengtsson E., Lamberger B. Five-year follow-up study of cases suggestive of acute myocarditis. Am Heart J. 1966 Dec;72(6):751–763. doi: 10.1016/0002-8703(66)90158-x. [DOI] [PubMed] [Google Scholar]
  3. Berg K. J., Førre O., Bjerkhoel F., Amundsen E., Djøseland O., Rugstad H. E., Westre B. Side effects of cyclosporin A treatment in patients with rheumatoid arthritis. Kidney Int. 1986 Jun;29(6):1180–1187. doi: 10.1038/ki.1986.125. [DOI] [PubMed] [Google Scholar]
  4. Bergström K., Erikson U., Nordbring F., Nordgren B., Parrow A. Acute non-rheumatic myopericarditis: a follow-up study. Scand J Infect Dis. 1970;2(1):7–16. doi: 10.3109/inf.1970.2.issue-1.02. [DOI] [PubMed] [Google Scholar]
  5. Bowles N. E., Richardson P. J., Olsen E. G., Archard L. C. Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet. 1986 May 17;1(8490):1120–1123. doi: 10.1016/s0140-6736(86)91837-4. [DOI] [PubMed] [Google Scholar]
  6. Cambridge G., MacArthur C. G., Waterson A. P., Goodwin J. F., Oakley C. M. Antibodies to Coxsackie B viruses in congestive cardiomyopathy. Br Heart J. 1979 Jun;41(6):692–696. doi: 10.1136/hrt.41.6.692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cassling R. S., Linder J., Sears T. D., Waller B. F., Rogler W. C., Wilson J. E., Kugler J. D., Kay D. H., Dillon J. C., Slack J. D. Quantitative evaluation of inflammation in biopsy specimens from idiopathically failing or irritable hearts: experience in 80 pediatric and adult patients. Am Heart J. 1985 Oct;110(4):713–720. doi: 10.1016/0002-8703(85)90447-8. [DOI] [PubMed] [Google Scholar]
  8. Daly K., Richardson P. J., Olsen E. G., Morgan-Capner P., McSorley C., Jackson G., Jewitt D. E. Acute myocarditis. Role of histological and virological examination in the diagnosis and assessment of immunosuppressive treatment. Br Heart J. 1984 Jan;51(1):30–35. doi: 10.1136/hrt.51.1.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dec G. W., Jr, Palacios I. F., Fallon J. T., Aretz H. T., Mills J., Lee D. C., Johnson R. A. Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med. 1985 Apr 4;312(14):885–890. doi: 10.1056/NEJM198504043121404. [DOI] [PubMed] [Google Scholar]
  10. Eckstein R., Mempel W., Bolte H. D. Reduced suppressor cell activity in congestive cardiomyopathy and in myocarditis. Circulation. 1982 Jun;65(6):1224–1229. doi: 10.1161/01.cir.65.6.1224. [DOI] [PubMed] [Google Scholar]
  11. Edwards W. D., Holmes D. R., Jr, Reeder G. S. Diagnosis of active lymphocytic myocarditis by endomyocardial biopsy: quantitative criteria for light microscopy. Mayo Clin Proc. 1982 Jul;57(7):419–425. [PubMed] [Google Scholar]
  12. Fenoglio J. J., Jr, Ursell P. C., Kellogg C. F., Drusin R. E., Weiss M. B. Diagnosis and classification of myocarditis by endomyocardial biopsy. N Engl J Med. 1983 Jan 6;308(1):12–18. doi: 10.1056/NEJM198301063080103. [DOI] [PubMed] [Google Scholar]
  13. Fletcher G. F., Coleman M. T., Feorino P. M., Marine W. M., Wenger N. K. Viral antibodies in patients with primary myocardial disease. Am J Cardiol. 1968 Jan;21(1):6–10. doi: 10.1016/0002-9149(68)90006-4. [DOI] [PubMed] [Google Scholar]
  14. Fowles R. E., Bieber C. P., Stinson E. B. Defective in vitro suppressor cell function in idiopathic congestive cardiomyopathy. Circulation. 1979 Mar;59(3):483–491. doi: 10.1161/01.cir.59.3.483. [DOI] [PubMed] [Google Scholar]
  15. French W. J., Siegel R. J., Cohen A. H., Laks M. M. Yield of endomyocardial biopsy in patients with biventricular failure. Comparison of patients with normal vs reduced left ventricular ejection fraction. Chest. 1986 Aug;90(2):181–184. doi: 10.1378/chest.90.2.181. [DOI] [PubMed] [Google Scholar]
  16. Fuster V., Gersh B. J., Giuliani E. R., Tajik A. J., Brandenburg R. O., Frye R. L. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol. 1981 Mar;47(3):525–531. doi: 10.1016/0002-9149(81)90534-8. [DOI] [PubMed] [Google Scholar]
  17. Gerzen P., Granath A., Holmgren B., Zetterquist S. Acute myocarditis. A follow-up study. Br Heart J. 1972 Jun;34(6):575–583. doi: 10.1136/hrt.34.6.575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hayakawa M., Inoh T., Yokota Y., Kawanishi H., Matsumoto K., Kumaki T., Fukuzaki H. A long-term follow-up study of acute viral and idiopathic myocarditis. Jpn Circ J. 1983 Nov;47(11):1304–1309. doi: 10.1253/jcj.47.1304. [DOI] [PubMed] [Google Scholar]
  19. Hosenpud J. D., McAnulty J. H., Niles N. R. Lack of objective improvement in ventricular systolic function in patients with myocarditis treated with azathioprine and prednisone. J Am Coll Cardiol. 1985 Oct;6(4):797–801. doi: 10.1016/s0735-1097(85)80485-x. [DOI] [PubMed] [Google Scholar]
  20. Huber S. A., Lodge P. A. Coxsackievirus B-3 myocarditis in Balb/c mice. Evidence for autoimmunity to myocyte antigens. Am J Pathol. 1984 Jul;116(1):21–29. [PMC free article] [PubMed] [Google Scholar]
  21. Huber S. A., Lodge P. A. Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice. Am J Pathol. 1986 Feb;122(2):284–291. [PMC free article] [PubMed] [Google Scholar]
  22. Kahan B. D. Immunosuppressive therapy with cyclosporine for cardiac transplantation. Circulation. 1987 Jan;75(1):40–56. doi: 10.1161/01.cir.75.1.40. [DOI] [PubMed] [Google Scholar]
  23. Kaye M. P. The Registry of the International Society for Heart Transplantation: fourth official report--1987. J Heart Transplant. 1987 Mar-Apr;6(2):63–67. [PubMed] [Google Scholar]
  24. Levander-Lindgren M. Studies in myocarditis. IV. Late prognosis. Cardiologia. 1965;47(4):209–220. [PubMed] [Google Scholar]
  25. Mason J. W., Billingham M. E., Ricci D. R. Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy. Am J Cardiol. 1980 May;45(5):1037–1044. doi: 10.1016/0002-9149(80)90174-5. [DOI] [PubMed] [Google Scholar]
  26. Neu N., Rose N. R., Beisel K. W., Herskowitz A., Gurri-Glass G., Craig S. W. Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol. 1987 Dec 1;139(11):3630–3636. [PubMed] [Google Scholar]
  27. Nippoldt T. B., Edwards W. D., Holmes D. R., Jr, Reeder G. S., Hartzler G. O., Smith H. C. Right Ventricular endomyocardial biopsy: clinicopathologic correlates in 100 consecutive patients. Mayo Clin Proc. 1982 Jul;57(7):407–418. [PubMed] [Google Scholar]
  28. O'Connell J. B., Costanzo-Nordin M. R., Subramanian R., Robinson J. A., Wallis D. E., Scanlon P. J., Gunnar R. M. Peripartum cardiomyopathy: clinical, hemodynamic, histologic and prognostic characteristics. J Am Coll Cardiol. 1986 Jul;8(1):52–56. doi: 10.1016/s0735-1097(86)80091-2. [DOI] [PubMed] [Google Scholar]
  29. O'Connell J. B., Fowles R. E., Robinson J. A., Subramanian R., Henkin R. E., Gunnar R. M. Clinical and pathologic findings of myocarditis in two families with dilated cardiomyopathy. Am Heart J. 1984 Jan;107(1):127–135. doi: 10.1016/0002-8703(84)90146-7. [DOI] [PubMed] [Google Scholar]
  30. O'Connell J. B., Henkin R. E., Robinson J. A., Subramanian R., Scanlon P. J., Gunnar R. M. Gallium-67 imaging in patients with dilated cardiomyopathy and biopsy-proven myocarditis. Circulation. 1984 Jul;70(1):58–62. doi: 10.1161/01.cir.70.1.58. [DOI] [PubMed] [Google Scholar]
  31. O'Connell J. B., Robinson J. A., Gunnar R. M., Scanlon P. J. Clinical aspects of virus/immune myocarditis. Heart Vessels Suppl. 1985;1:102–106. doi: 10.1007/BF02072373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Obeyesekere I., Hermon Y. Arbovirus heart disease: myocarditis and cardiomyopathy following dengue and chikungunya fever--a follow-up study. Am Heart J. 1973 Feb;85(2):186–194. doi: 10.1016/0002-8703(73)90459-6. [DOI] [PubMed] [Google Scholar]
  33. Orinius E. The late cardiac prognosis after Coxsackie-B infection. Acta Med Scand. 1968 Mar;183(3):235–237. doi: 10.1111/j.0954-6820.1968.tb10470.x. [DOI] [PubMed] [Google Scholar]
  34. Paque R. E., Gauntt C. J., Nealon T. J., Trousdale M. D. Assessment of cell-mediated hypersensitivity against coxsackievirus B3 viral-induced myocarditis utilizing hypertonic salt extracts of cardiac tissue. J Immunol. 1978 May;120(5):1672–1678. [PubMed] [Google Scholar]
  35. Parrillo J. E., Aretz H. T., Palacios I., Fallon J. T., Block P. C. The results of transvenous endomyocardial biopsy can frequently be used to diagnose myocardial diseases in patients with idiopathic heart failure. Endomyocardial biopsies in 100 consecutive patients revealed a substantial incidence of myocarditis. Circulation. 1984 Jan;69(1):93–101. doi: 10.1161/01.cir.69.1.93. [DOI] [PubMed] [Google Scholar]
  36. Reyes M. P., Ho K. L., Smith F., Lerner A. M. A mouse model of dilated-type cardiomyopathy due to coxsackievirus B3. J Infect Dis. 1981 Sep;144(3):232–236. doi: 10.1093/infdis/144.3.232. [DOI] [PubMed] [Google Scholar]
  37. Sainani G. S., Krompotic E., Slodki S. J. Adult heart disease due to the Coxsackie virus B infection. Medicine (Baltimore) 1968 Mar;47(2):133–147. doi: 10.1097/00005792-196803000-00003. [DOI] [PubMed] [Google Scholar]
  38. Sekiguchi M., Hiroe M., Take M., Hirosawa K. Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis. Concepts through a study employing endomyocardial biopsy. II. Myocarditis. Jpn Circ J. 1980 Apr;44(4):264–273. doi: 10.1253/jcj.44.264. [DOI] [PubMed] [Google Scholar]
  39. Smith W. G. Coxsackie B myopericarditis in adults. Am Heart J. 1970 Jul;80(1):34–46. doi: 10.1016/0002-8703(70)90035-9. [DOI] [PubMed] [Google Scholar]
  40. Tindall R. S., Rollins J. A., Phillips J. T., Greenlee R. G., Wells L., Belendiuk G. Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis. N Engl J Med. 1987 Mar 19;316(12):719–724. doi: 10.1056/NEJM198703193161205. [DOI] [PubMed] [Google Scholar]
  41. Torp A. Incidence of congestive cardiomyopathy. Postgrad Med J. 1978 Jul;54(633):435–439. doi: 10.1136/pgmj.54.633.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Unverferth D. V., Fetters J. K., Unverferth B. J., Leier C. V., Magorien R. D., Arn A. R., Baker P. B. Human myocardial histologic characteristics in congestive heart failure. Circulation. 1983 Dec;68(6):1194–1200. doi: 10.1161/01.cir.68.6.1194. [DOI] [PubMed] [Google Scholar]
  43. Vignola P. A., Aonuma K., Swaye P. S., Rozanski J. J., Blankstein R. L., Benson J., Gosselin A. J., Lister J. W. Lymphocytic myocarditis presenting as unexplained ventricular arrhythmias: diagnosis with endomyocardial biopsy and response to immunosuppression. J Am Coll Cardiol. 1984 Oct;4(4):812–819. doi: 10.1016/s0735-1097(84)80411-8. [DOI] [PubMed] [Google Scholar]
  44. Wilson F. M., Miranda Q. R., Chason J. L., Lerner A. M. Residual pathologic changes following murine coxsackie A and B myocarditis. Am J Pathol. 1969 May;55(2):253–265. [PMC free article] [PubMed] [Google Scholar]
  45. Yasuda T., Palacios I. F., Dec G. W., Fallon J. T., Gold H. K., Leinbach R. C., Strauss H. W., Khaw B. A., Haber E. Indium 111-monoclonal antimyosin antibody imaging in the diagnosis of acute myocarditis. Circulation. 1987 Aug;76(2):306–311. doi: 10.1161/01.cir.76.2.306. [DOI] [PubMed] [Google Scholar]
  46. Zee-Cheng C. S., Tsai C. C., Palmer D. C., Codd J. E., Pennington D. G., Williams G. A. High incidence of myocarditis by endomyocardial biopsy in patients with idiopathic congestive cardiomyopathy. J Am Coll Cardiol. 1984 Jan;3(1):63–70. doi: 10.1016/s0735-1097(84)80431-3. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES